| Title |
Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
|
|---|---|
| Published in |
International Journal of Nanomedicine, November 2021
|
| DOI | 10.2147/ijn.s347817 |
| Pubmed ID | |
| Authors |
Xiao-li Song, Rui-jun Ju, Yao Xiao, Xin Wang, Shuang Liu, Min Fu, Jing-jing Liu, Li-yan Gu, Xue-tao Li, Lan Cheng |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2021.
All research outputs
#20,710,927
of 23,310,485 outputs
Outputs from International Journal of Nanomedicine
#3,393
of 3,885 outputs
Outputs of similar age
#361,260
of 440,316 outputs
Outputs of similar age from International Journal of Nanomedicine
#30
of 46 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,885 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,316 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.